NCT02964377View on ClinicalTrials.gov

Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG

(+)- Epicatechin

Trial Locations (1)

95817

UC Davis Medical Center, Sacramento

Sponsors
All Listed Sponsors
collaborator

Cardero Therapeutics, Inc.

INDUSTRY

lead

Craig McDonald, MD

OTHER